Workflow
Changyao Group(300391)
icon
Search documents
长药控股(300391) - 2014 Q4 - 年度财报
2015-04-16 16:00
Financial Performance - The company's operating revenue for 2014 was ¥243,428,659.11, a decrease of 4.68% compared to ¥255,385,121.46 in 2013[15] - Operating profit fell to ¥18,577,999.98 in 2014, down 43.00% from ¥32,595,009.37 in the previous year[15] - The net profit attributable to shareholders decreased by 17.85% to ¥28,718,706.93 from ¥34,958,543.50 in 2013[15] - The weighted average return on equity dropped to 10.65% in 2014 from 19.17% in 2013, a decline of 8.52 percentage points[15] - The company reported a basic earnings per share of ¥0.5043, down 27.87% from ¥0.6992 in the previous year[15] - The gross margin for turbochargers decreased by 8.37% to 34.69%, while the revenue from other products increased by 52.68%[41] Assets and Liabilities - The total assets increased by 21.13% to ¥681,847,082.99 at the end of 2014, compared to ¥562,919,130.56 at the end of 2013[15] - The company's total liabilities decreased by 13.21% to ¥317,140,295.17 in 2014 from ¥365,416,546.67 in 2013[15] - The asset-liability ratio improved to 46.51% in 2014, down from 64.91% in 2013, a reduction of 18.40 percentage points[15] - Cash and cash equivalents increased by 456.49% to ¥29,828,142.21, reflecting improved liquidity[35] - The company's total assets included cash of ¥90,517,090.95, which represented 13.28% of total assets, a decrease of 3.52% from the previous year[42] Cash Flow - The net cash flow from operating activities was negative at -¥38,880,883.48, a significant decrease of 279.52% compared to ¥21,658,761.26 in 2013[15] - Operating cash inflow for 2014 was ¥143,908,463.73, a 1.19% increase from 2013, while cash outflow rose by 51.63% to ¥182,789,347.21, resulting in a net cash flow of -¥38,880,883.48[34] - The net cash flow from financing activities increased by 123.86% to ¥101,042,098.06, primarily due to increased funds raised from stock issuance[36] Research and Development - Research and development expenses totaled 16.16 million yuan, accounting for 6.64% of total revenue, with eight projects ongoing[32] - The company aims to enhance product technology and process control capabilities to maintain its core technological advantages and high cost-performance ratio[51] Shareholder Information - The company distributed a cash dividend of RMB 1.30 per 10 shares, totaling RMB 8,667,100.00, which represents 30.18% of the net profit attributable to shareholders[58] - The total distributable profit available for shareholders as of December 31, 2014, was RMB 106,287,175.93, with a net profit of RMB 30,920,132.54 for the year[55] Corporate Governance - The company has established a management system for insider information to ensure compliance with disclosure regulations[58] - The company maintains independent business operations and has a complete operational system, ensuring no financial guarantees or non-operational fund occupation by the controlling shareholder during the reporting period[128] - The board of directors and supervisory board are elected according to legal procedures, ensuring compliance with laws and regulations, and all members actively participate in training to enhance governance[129][130] Employee Information - The company employed a total of 750 staff, with 58% in production and auxiliary roles, 21% in administrative management, and 14% in technical positions[123] - As of December 31, 2014, the company had 117 disabled employees, representing 28.4% of the total workforce[124] Audit and Compliance - The audit opinion for the financial statements is unqualified, indicating that the financial statements fairly reflect the company's financial position and operating results for the year ended December 31, 2014[148] - The financial statements are prepared in Renminbi (RMB), with the unit specified as yuan[150] Market and Industry Risks - The company faced risks related to industry policies and macroeconomic fluctuations, which could impact demand for internal combustion engines[21] - The company is undergoing a transition in emission standards from National III to National IV, which may slow down product sales growth[21]
长药控股(300391) - 2014 Q3 - 季度财报
2014-10-21 16:00
康跃科技股份有限公司 2014 年第三季度报告 2014-019 2014 年 10 月 1 康跃科技股份有限公司 2014 年第三季度报告全文 康跃科技股份有限公司 2014 年第三季度报告全文 康跃科技股份有限公司 2014 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 第一节 重要提示 本公司董事会、监事会及其董事、监事、高级管理人员保证本报告所载资料不存在任何虚假记载、误 导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人郭锡禄、主管会计工作负责人郑树峰及会计机构负责人(会计主管人员)王德兴声明:保证 季度报告中财务报告的真实、完整。 2 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增 | | --- | --- | --- | --- | --- | | | | | | 减 | | 总资产(元) | 708,561,578.52 | | 562,919,130.56 | 25.87% | | ...